R&D

R&D

Pipeline
Pipeline
Clinical Trial Information
Clinical Trial Information

R&D News

View more
  • November 5, 2025 Pipeline ― State of New Product Development
  • October 23, 2025 Receipt of Complete Response Letter from U.S. FDA for investigational ND0612 pdf （199KB）
  • October 14, 2025 Anti-CD19 monoclonal antibody UPLIZNA® for I.V. Infusion 100mg Application for additional indication of generalized Myasthenia Gravis in Japan pdf （582KB）
  • August 1, 2025 Pipeline ― State of New Product Development
  • July 10, 2025 To initiate joint research aiming to create innovative cancer drugs in Targeted Alpha Therapy pdf （458KB）
  1. Tanabe Pharma Corporation
  2. R&D
  3. TOP
  • header-content
  • header-content

  • CLOSE
  • MENU

Site Search

If you agree to the use of cookies, please click the "Agree" button.
If you do not agree, please do not use this site. For details, please refer to the following page.

Privacy Policy

Agree

URL
 

田辺ファーマ株式会社のサイトを離れます。よろしいですか？
（別ウィンドウが開きます）

You are leaving the Tanabe Pharma Corporation’s website.
(A new window will be opened.)

はい / O.K.
いいえ / Cancel
  • footer-content